Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.
Statistics

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds
Systems Biology of Signal Transduction

Division of Systems Biology of Signal Transduction

Prof. Dr. Ursula Klingmüller

Created with Biorender
© dkfz.de

Bridging from the cellular to the organ scale, the division aims at unraveling molecular mechanisms regulating cell communication and cell decisions, as a failure of these control mechanisms contributes to tumor development. We combine quantitative technologies with mechanism-based mathematical modeling to enable early detection and personalized treatment of cancer to prevent tumor progression and improve quality of life.

Cellular responses are regulated by a multitude of extracellular signals received by cell surface receptors. Within cells the information is processed through complex intracellular signaling networks that in turn impinge on gene regulation. The dynamics of signal transduction is affected by the metabolic state of cells as well as the impact of signal transduction on metabolism. These multitude of reactions are integrated and converted to phenotypic responses such as proliferation, survival and differentiation. The majority of these responses are non-linear and operate on very different time scales, ranging from minutes to hours and days. Due to this complexity, it is of advantage to employ mathematical modelling approaches. Data-based mathematical models not only enable rapid testing of hypotheses to uncover deregulation in cancer, but also facilitate the prediction of trajectories such as disease development and support the establishment optimized intervention strategies to change the course of a disease.

In close cooperation with our mathematical modelling partners and the clinical partners, we are advancing cellular model systems to include an authentic extracellular matrix, developing cutting edge mass spectrometry approaches for clinical proteomics and increasingly combine AI-based modelling approaches with dynamic pathway modeling. The key areas of medical interest are processes determining the development of leukemia, lung cancer or liver cancer.

Areas of focus in the division are:

  1. Advancing systems medicine approaches for clinical translation through standardization of workflows for high-quality data generation and the development of predictive mathematical models
  2. Bridging from the single cell to the cell population and organ level to unravel principal mechanisms controlling erythropoietin (Epo)-induced cellular responses in the hematopoietic system.
  3. Resolving interactions in the tumor microenvironment determining lung cancer development and personalized optimization of intervention strategies.
  4. Deciphering the interconnection of signal transduction and metabolism to unravel mechanisms controlling the compensation of liver injury due to drugs or viral infection and to establish model-based biomarkers for early detection of liver cancer.
OUTLOOK
Our ambition is to establish mathematical models for the prediction of disease trajectories to support early detection of cancer and to establish effective intervention strategies for converting an aggressively progressing cancer to a controllable disease. Therefore, we continue to develop integrative models linking signal transduction, metabolism and phenotypic responses that are essential building blocks for the establishment of mechanistic multi-scale models to predict the impact of cellular alterations on the entire organ. Our mass spectrometry based clinical proteomics pipeline greatly increases the possibilities to generate reliable quantitative data and through the combination of AI-based pattern recognition with dynamic pathway modeling much extends the development of predictive models. Through our clinical partners we have access to high-quality patient samples that allow to adapt our predictive mathematical models to disease states and to resolve mechanisms leading from chronic diseases to cancer and impacting the heart.

Contact

Prof. Dr. Ursula Klingmüller
Systems Biology of Signal Transduction (B200)
Deutsches Krebsforschungszentrum
Im Neuenheimer Feld 280
69120 Heidelberg

Selected Publications

  • Adlung, L., et al. Cell-to-cell variability in JAK2/STAT5 pathway components and cytoplasmic volumes defines survival threshold in erythroid progenitor cells. Cell Reports 36(6), 109507 (2021)
  • Chakraborty, S. et al. Erythropoietin-driven dynamic proteome adaptations during erythropoiesis prevent iron overload in the developing embryo. Cell Reports 40(12):111360 (2022)
  • Lucarelli, P. et al. Resolving the Combinatorial Complexity of Smad Protein Complex Formation and Its Link to Gene Expression. Cell Systems 6(1):75-89.e11 (2018)
  • Kok, F. et al. Disentangling molecular mechanisms regulating sensitization of interferon alpha signal transduction. Molecular Systems Biology 16(7):e8955 (2020)
to top
powered by webEdition CMS